Your browser doesn't support javascript.
loading
Usage of compromised lung volume in monitoring steroid therapy on severe COVID-19.
Su, Ying; Qiu, Ze-Song; Chen, Jun; Ju, Min-Jie; Ma, Guo-Guang; He, Jin-Wei; Yu, Shen-Ji; Liu, Kai; Lure, Fleming Y M; Tu, Guo-Wei; Zhang, Yu-Yao; Luo, Zhe.
Afiliación
  • Su Y; Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Qiu ZS; School of Information Science and Technology, ShanghaiTech University, Shanghai, China.
  • Chen J; Department of Radiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Ju MJ; Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ma GG; Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • He JW; School of Information Science and Technology, ShanghaiTech University, Shanghai, China.
  • Yu SJ; Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Liu K; Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lure FYM; MS Technologies, Rockville, MD, USA.
  • Tu GW; Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. tu.guowei@zs-hospital.sh.cn.
  • Zhang YY; School of Information Science and Technology, ShanghaiTech University, Shanghai, China. zhangyy8@shanghaitech.edu.cn.
  • Luo Z; Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. luo.zhe@zs-hospital.sh.cn.
Respir Res ; 23(1): 105, 2022 Apr 29.
Article en En | MEDLINE | ID: mdl-35488261
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Respir Res Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Respir Res Año: 2022 Tipo del documento: Article País de afiliación: China